TRPM7 Human shRNA Plasmid Kit (Locus ID 54822)

SKU
TL320704
TRPM7 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
  $1,013.00
In Stock*
Specifications
Specifications
Product Data
Locus ID 54822
Synonyms ALSPDC; CHAK; CHAK1; LTrpC-7; LTRPC7; TRP-PLIK
Vector pGFP-C-shLenti
E. coli Selection Chloramphenicol (34 ug/ml)
Mammalian Cell Selection Puromycin
Format Lentiviral plasmids
Components TRPM7 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 54822). 5µg purified plasmid DNA per construct
29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free.
RefSeq NM_001301212, NM_017672, NR_149152, NR_149153, NR_149154, NM_017672.1, NM_017672.2, NM_017672.3, NM_017672.4, NM_017672.5, NM_001301212.1, BC028843, BC051024, BC128987, BC128988, BC169233, BC169234, BC169235, NM_001301212.2, NM_017672.6
UniProt ID Q96QT4
Summary This gene belongs to the melastatin subfamily of transient receptor potential family of ion channels. The protein encoded by this gene is both an ion channel and a serine/threonine protein kinase. The kinase activity is essential for the ion channel function, which serves to increase intracellular calcium levels and to help regulate magnesium ion homeostasis. The encoded protein is involved in cytoskeletal organization, cell adhesion, cell migration and organogenesis. Defects in this gene are a cause of amyotrophic lateral sclerosis-parkinsonism/dementia complex of Guam. The gene may also be associated with defects of cardiac function. provided by RefSeq, Aug 2017
shRNA Design These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Storage Store at -20°C
Shipping Ambient
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

TRPM7 via calcineurin/NFAT pathway mediates metastasis and chemotherapeutic resistance in head and neck squamous cell carcinoma
Chen, Huang, Hsieh et al
Aging (Albany NY) (2022) 14 (12), 5250-5270 DOI: 10.18632/aging.204154
Cited by 18
AI Summary: OriGene’s TRPM7 shRNA lentiviral particles (two shRNA clones) were used to specifically knock down TRPM7 expression, enabling the authors to study its role in metastasis and chemoresistance in head and neck squamous cell carcinoma.
Snippet: o observe the role of TRPM7 in regulation of cancer metastasis capacity and chemoresistance, short hairpin RNA (shRNA)-mediated knockdown was employed. The shRNA-mediated lentivirus was acquired from OriGene Corp. (Rockville, MD, USA) and produced according to the manufacturer guidelines. The expression of TRPM7 was intended to knock down by adopting two clones of shRNA: clone #1 (shRNA1, clone ID
FigureFigureFigure
Isoproterenol-Dependent Activation of TRPM7 Protects Against Neurotoxin-Induced Loss of Neuroblastoma Cells
Sun, Kamat, Singh
Front Physiol (2020) 11, 305 DOI: 10.3389/fphys.2020.00305
Cited by 10
AI Summary: OriGene products, specifically the TRPM7 shRNA plasmids for gene silencing and full-length HA-TRPM7 plasmids for overexpression, were used to manipulate TRPM7 expression in SH-SY5Y neuroblastoma cells, enabling the study of TRPM7’s role in cell survival under neurotoxic conditions.
Snippet: For the silencing of TRPM7 expression, shRNA plasmids that specifically targets the coding sequence of human TRPM7 was obtained from Origene (Rockville, MD, United States). … For TRPM7 overexpression, full length HA-TRPM7 plasmids was used to transiently overexpress TRPM7 in these cells. …
FigureFigureFigure
TGFβ-induced epithelial-to-mesenchymal transition in prostate cancer cells is mediated via TRPM7 expression
Sun, Schaar, Sukumaran et al
Mol. Carcinog. (2018)
AI Summary: OriGene’s shRNA plasmid targeting human TRPM7 was used to silence TRPM7 expression in prostate cancer cells, enabling the authors to demonstrate that TRPM7 is essential for TGFβ-induced cell migration and epithelial-to-mesenchymal transition.
Snippet: in complete media, until reaching 90% confluence. For transfection experiments, shRNA plasmid that targets the coding sequence of human TRPM7 were obtained from Origene. Cells were transfected with individual shRNA (50nM) or control plasmid (50nM) using
Showing 1-3 of 3 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products